Phase II Clinical Investigation of Gemcitabine in Advanced Soft Tissue Sarcomas and Window Evaluation of Dose Rate on Gemcitabine Triphosphate Accumulation

Cancer statistics, 2000

2000 • 3,907 citations

Optimal two-stage designs for phase II clinical trials

1989 • 3,494 citations

Action of 2',2'-difluorodeoxycytidine on DNA synthesis.

1991 • 868 citations

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

1991 • 755 citations

Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2',2'-difluorodeoxycytidine.

1990 • 393 citations

Cellular elimination of 2',2'-difluorodeoxycytidine 5'-triphosphate: a mechanism of self-potentiation.

1992 • 323 citations

Saturation of 2?, 2?-difluorodeoxycytidine 5?-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine

1991 • 250 citations

Metabolism of 2',2'-difluoro-2'-deoxycytidine and radiation sensitization of human colon carcinoma cells.

1994 • 229 citations

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study.

1992 • 216 citations

Modulatory activity of 2',2'-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides.

1990 • 163 citations

Nucleotide specificity of human deoxycytidine kinase.

1992 • 121 citations

Gemcitabine in soft tissue or bone sarcoma resistant to standard chemotherapy: a phase II study

2000 • 106 citations

Clinical results of a pharmacodynamically-based strategy for higher dosing of gemcitabine in patients with solid tumors

1998 • 93 citations

Expression of ERCC1 antisense RNA abrogates gemicitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair.

2000 • 88 citations

A Phase I trial of weekly gemcitabine administered as a prolonged infusion in patients with pancreatic cancer and other solid tumors

1997 • 83 citations

Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.

1980 • 78 citations

Phase II trial of gemcitabine in patients with pretreated advanced soft tissue sarcomas

2000 • 69 citations

New agents in the treatment of soft-tissue sarcomas

2000 • 8 citations